Anti-AAV9 VP1/Capsid Protein VP1 Antibody (SAA2446) from ProteoGenix; catalogue ARO-A22936; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-AAV9 VP1/Capsid Protein VP1 Antibody (SAA2446) is a highly specific and reliable tool for the detection and analysis of Adeno-Associated Virus serotype 9 (AAV9) VP1/Capsid Protein. This monoclonal antibody is designed and developed by our team of expert scientists in the field of biotechnology.
The AAV9 VP1/Capsid Protein is an essential component of the Adeno-Associated Virus serotype 9. It plays a crucial role in the viral life cycle by facilitating the entry of the virus into host cells. This protein is also responsible for viral attachment and endosomal escape, making it a key target for research and development in the field of gene therapy.
The Anti-AAV9 VP1/Capsid Protein VP1 Antibody is specifically designed for the detection and quantification of AAV9 VP1/Capsid Protein in various biological samples. It can be used for a wide range of applications, including Western blotting, immunofluorescence, and immunohistochemistry. This antibody is also suitable for flow cytometry and ELISA assays.
The Anti-AAV9 VP1/Capsid Protein VP1 Antibody has been extensively tested and validated for its specificity and sensitivity in various experimental conditions. It has been successfully used in studies involving AAV9-mediated gene delivery, viral tropism, and viral capsid assembly. This antibody has also shown promising results in preclinical studies for the development of AAV9-based gene therapies.
Our Anti-AAV9 VP1/Capsid Protein VP1 Antibody (SAA2446) is a powerful and reliable tool for the detection and analysis of AAV9 VP1/Capsid Protein. With its high specificity and sensitivity, this antibody is ideal for a wide range of applications, including Western blotting, immunofluorescence, and immunohistochemistry. It has been extensively tested and validated for its performance in various experimental conditions, making it a top choice for AAV9 research.
ProteoGenix catalogue number ARO-A22936. For research use only.
Target: VP1/Capsid; Clonality: Monoclonal Antibody; Applications: Neutralization, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | Neutralization |
|---|---|---|---|---|---|---|---|---|---|
| VP1/Capsid |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
